Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in Florida

If you’re a psychiatrist or psychiatric nurse practitioner navigating telehealth, you’ve probably googled ‘can I prescribe Adderall via telemedicine?’ or ‘what’s the difference between NP and MD prescribing authority?’ more than once. You’re not alone. Between evolving DEA rules, state-by-state scope of practice laws, and collaborative agreement requirements that change depending on where your patient sits during the video call, it’s enough to make anyone’s head spin.

Let’s cut through the confusion. This guide breaks down exactly what psychiatrists and PMHNPs can prescribe via telehealth in 2026, how state laws differ, and what the reimbursement landscape looks like. Whether you’re an MD supervising NPs, a PMHNP trying to figure out if you need a collaborating physician in your state, or someone considering a telehealth platform to expand your practice, this is your roadmap.

What Psychiatrists Can Prescribe via Telehealth (Spoiler: Pretty Much Everything)

The good news first: As a fully licensed psychiatrist (MD or DO), you have broad authority to prescribe psychiatric medications through telehealth in 2026. This includes controlled substances like stimulants for ADHD, benzodiazepines for anxiety, and buprenorphine for opioid use disorder.

The Federal Picture: DEA Flexibility Still in Place

Historically, the Ryan Haight Act required an in-person exam before prescribing controlled substances. But since the COVID-19 public health emergency, the DEA has waived this requirement for telemedicine — and as of early 2026, those flexibilities remain extended through December 31, 2025 (texasnp.org) (natlawreview.com).

What this means practically: You can start a new patient on Adderall, Vyvanse, Xanax, or other Schedule II-V controlled substances after a video consultation, without needing to see them in your office first. You’re conducting a legitimate patient evaluation via secure video — that counts.

The caveat: The DEA has proposed implementing new permanent rules that could require things like a special telemedicine registration or impose 30-day supply limits for initial prescriptions. Keep an eye on DEA announcements in late 2024/early 2025. Until then, you’re clear to prescribe under current waivers.

State-Specific Rules: Where It Gets Interesting

While federal law sets the baseline, state laws can add restrictions. Here’s what you need to know for the major markets:

Florida: One of the most permissive. Florida law explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (www.flsenate.gov). The state carved out mental health from restrictions that apply to chronic pain management. A Florida-licensed psychiatrist can initiate ADHD stimulants or anti-anxiety meds in a telemedicine visit without issue.

Texas: Generally permits telemedicine prescribing if the standard of care is met, but prohibits teleprescribing opioids for chronic pain (not usually relevant in psychiatry). For psychiatric conditions like ADHD or anxiety, Texas psychiatrists can prescribe controlled substances via video under current federal allowances (www.cchpca.org). Important: Texas requires checking the state Prescription Monitoring Program (PMP) before prescribing any controlled substance.

New York: Recently updated its rules to align with federal telehealth flexibilities. In mid-2025, New York finalized regulations that permit telemedicine prescriptions of controlled substances when consistent with federal law (www.nixonpeabody.com). Translation: if the DEA says it’s okay, New York says it’s okay. NY psychiatrists can continue teleprescribing under the federal waiver without state-level non-compliance concerns.

California: Requires a ‘good faith exam’ before prescribing, but a telehealth video exam absolutely qualifies (natlawreview.com). California psychiatrists can prescribe controlled substances after a thorough telehealth evaluation. You must enroll in CURES (California’s PMP) and check it before prescribing Schedule II-IV drugs.

Pennsylvania & Illinois: Follow federal guidelines. Both states recognize telehealth exams as valid for establishing the patient-physician relationship necessary for prescribing. Illinois has strong telehealth parity laws requiring insurers to cover and pay for telehealth mental health services at the same rate as in-person through at least 2027.

What About Audio-Only Visits?

Medicare and some states now reimburse for audio-only (phone) mental health visits to improve access for patients without video capability. This was extended through 2024-2025 for mental health specifically (aapp.org). While initial evaluations for controlled substances typically require video, brief follow-up med checks can sometimes be done by phone where allowed — a flexibility worth knowing about for rural or underserved patients.

The Bottom Line for Psychiatrists

You have the authority. The key is staying compliant:

• Use secure, HIPAA-compliant video for initial evaluations and controlled substance prescriptions
• Check your state’s PMP before prescribing Schedule II-IV medications
• Document thoroughly — note the visit was via telemedicine, the patient’s location, and that you obtained consent
• Stay licensed in the state where your patient is physically located during the visit
• Watch for DEA updates as permanent rules may require adjustments in 2025

If you’re practicing on a platform like Klarity Health, these compliance requirements are typically built into the workflow — the platform ensures HIPAA compliance, you focus on clinical care.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs. MD Prescribing: The Authority Gap by State

Here’s where it gets more complex. While psychiatrists have universal prescribing authority, psychiatric nurse practitioners operate under a patchwork of state-specific rules that range from full independence to requiring physician supervision for their entire career.

The Three Models of NP Practice

States fall into three categories for NP scope of practice:

1. Full Practice Authority (FPA) States — NPs can practice and prescribe independently, no physician oversight required. As of 2025, approximately 34 states have full practice authority (www.nursepractitioneronline.com). Examples include Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, and many others. A PMHNP in these states can open their own practice, diagnose, and prescribe all psychiatric medications (including controlled substances) under their own DEA registration.

2. Reduced Practice States — NPs need a collaborative agreement with a physician, usually for prescribing authority. The physician doesn’t supervise day-to-day but must be available for consultation and periodic chart review. Many of these states have a pathway to independence after gaining experience. Examples: New York (independent after 3,600 hours), Illinois (independent after 4,000 hours + 250 CE hours), California (transitioning to independence with experience).

3. Restricted Practice States — NPs must practice under continuous physician supervision or delegation. No pathway to independence regardless of experience. Examples: Texas, Florida (for psych NPs specifically), and some Southern states. In these states, a PMHNP cannot prescribe without a physician’s explicit delegation and ongoing oversight.

State-by-State Breakdown for Priority Markets

California: Transitioning from restricted to full practice through AB 890. As of 2023, experienced NPs (3+ years) can become ‘103 NPs’ and practice without physician supervision in group settings. By January 2026, those NPs can become ‘104 NPs’ with full independent practice authority including prescribing (www.rn.ca.gov). New graduate PMHNPs still need physician-supervised standardized procedures for their first 3 years.

Texas: One of the most restrictive. Texas PMHNPs must have a Prescriptive Authority Agreement with a physician to prescribe any medication (www.bon.texas.gov). They cannot prescribe Schedule II controlled substances in outpatient settings except in very limited circumstances (like hospice). The physician can supervise no more than 7 NPs/PAs at once (capitol.texas.gov), and must meet with the NP monthly for the first 3 years, quarterly thereafter. This makes telehealth practice more complex for Texas NPs — many work for larger organizations that provide the supervising physician.

Florida: Created an ‘Autonomous APRN’ category in 2020, but psychiatric NPs were excluded (www.npschools.com). Autonomy was granted only to primary care NPs (family, internal medicine, pediatrics). PMHNPs in Florida must practice under a physician protocol and must have a psychiatrist as their collaborating physician to prescribe psychotropic controlled substances (www.flsenate.gov). There’s a carve-out: ‘psychiatric nurses’ with 2+ years experience can prescribe psychiatric medications beyond the normal 7-day Schedule II limit, but still need that psychiatrist relationship.

New York: One of the more progressive states. PMHNPs must initially practice under a collaborative agreement with a physician for their first 3,600 hours (roughly 2 years). After that, they can practice independently — no written agreement required, just an attestation of having informal ‘collaborative relationships’ for referrals (www.jdsupra.com). This change was made permanent in 2022. Many experienced NY PMHNPs now run independent practices, especially filling gaps in upstate underserved areas.

Pennsylvania: Still requires collaborative agreements indefinitely — no pathway to full practice authority yet, though legislation has been proposed (www.pacnp.org). PA PMHNPs can prescribe Schedule II-V controlled substances if their collaborating physician approves it, but Schedule II prescriptions are limited to 30-day supplies and require physician notification within 24 hours. The physician must review a portion of the NP’s charts regularly (often 10% quarterly). Finding a collaborating psychiatrist can be challenging and costly in PA.

Illinois: Has a transition-to-independence model. PMHNPs must complete 4,000 hours of practice under a collaborative agreement plus 250 hours of continuing education in advanced pharmacology, then they can apply for ‘Full Practice Authority’ (www.nursepractitionerlicense.com). Until then, they must have a collaborative agreement and the collaborating physician’s name appears on their prescriptions as the delegating practitioner. Once granted FPA, Illinois PMHNPs can prescribe independently, including controlled substances.

What Collaborative Agreements Actually Require

In states requiring collaboration, these agreements typically specify:

• Scope of practice — what conditions the NP can treat, which medications they can prescribe
• Physician availability — how quickly the physician must respond to consults, backup coverage arrangements
• Chart review requirements — how many charts the physician reviews and how often (often 10% quarterly, or all Schedule II prescriptions)
• Meeting schedules — some states mandate periodic face-to-face meetings (Texas requires monthly for first 3 years)
• State board filing — some states require submitting the agreement to the nursing board

These requirements create real pain points. Finding a collaborating psychiatrist can take months. Many physicians charge a fee (sometimes $1,000-5,000/year) to serve as a collaborator. For telehealth NPs practicing in multiple states, you need separate collaborative agreements for each restricted state — and those agreements must comply with that state’s specific rules.

The Reimbursement Difference

Even when PMHNPs have similar legal authority to psychiatrists, Medicare reimburses NP services at 85% of physician rates when billed under the NP’s own NPI (www.nursepractitioneronline.com). Many private insurers follow similar policies.

For example, if Medicare pays a psychiatrist $95 for a 15-minute med check (CPT 99213), an NP would receive about $81 for the same service. For a 25-minute follow-up (99214) paying $136 for an MD, the NP gets about $115.

Some states have passed ‘equal reimbursement’ laws mandating insurers pay NPs the same as MDs for identical services, but this isn’t universal. From a practice economics standpoint, this differential matters when projecting revenue.

What the Economics Really Look Like: Patient Acquisition in Psychiatry

Let’s talk numbers — because understanding patient acquisition costs and revenue is critical to building a sustainable practice.

The DIY Marketing Reality

If you’re thinking about building your own patient base through SEO, Google Ads, or directory listings, here’s what you need to know:

SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You’re competing with established practices, large health systems, and platforms with SEO teams. Most solo providers don’t have the expertise or patience for this.

Google Ads for mental health keywords are expensive — $15-40+ per click is common for terms like ‘psychiatrist near me’ or ‘ADHD doctor.’ Even worse, most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you factor in ad spend testing, optimization, and conversion rates.

Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you’re competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+ per lead), and you still need to pay the monthly subscription. Total monthly cost adds up fast.

When you factor in all costs — agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of SEO investment before results, and failed campaigns — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.

And here’s the thing: even at those costs, you’re gambling. You might spend $3,000-5,000/month on marketing with zero patients to show for it in month one, maybe a trickle in month three, and hopefully a steady flow after six months. Maybe.

The Platform Economics Alternative

This is where a platform model like Klarity Health makes economic sense. Instead of spending thousands upfront on marketing with uncertain results, you pay a standard listing fee per new patient lead — similar to Zocdoc’s model, but the key differences:

• No upfront marketing spend or monthly subscription fees eating into your cash flow
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs for video, scheduling, EHR)
• Both insurance and cash-pay patient flow depending on your preferences
• You control your schedule — only pay when you see patients

Frame it this way: instead of gambling $3,000-5,000/month on marketing that might work, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. uncertain marketing channels.

The math is straightforward. If Medicare pays you $173 for an initial psychiatric evaluation and $95-136 for follow-ups, even accounting for a per-appointment fee to the platform, your net revenue per patient is substantially positive — and you didn’t spend months and thousands of dollars acquiring that patient yourself.

State Market Conditions & Provider Demand

The patient demand is absolutely there:

• Texas and Florida have some of the worst psychiatrist-to-population ratios in the nation (1 psychiatrist per ~8,500–9,000 residents) (www.healingpsychiatryflorida.com). This translates to high demand for prescribers and ample telehealth patient volume.

• California has over 11 million residents living in mental health professional shortage areas (www.healingpsychiatryflorida.com), even though it has more psychiatrists per capita than Texas or Florida.

• New York has high concentration of psychiatrists in NYC (1:2,900 residents statewide) (www.healingpsychiatryflorida.com), but upstate regions remain desperately undersupplied, with ~197 mental health shortage areas.

• Pennsylvania and Illinois fall in the middle but still have significant rural shortages driving telehealth demand.

The provider shortage means patients are actively seeking care and willing to use telehealth. The challenge isn’t finding patients — it’s acquiring them cost-effectively.

Reimbursement: What You’ll Actually Get Paid

Understanding reimbursement is crucial for projecting practice revenue. Here’s what medication management visits pay in 2026:

Medicare Rates (The Benchmark)

Medicare rates are useful benchmarks since many insurers peg their fees to Medicare’s schedule:

• Initial psychiatric evaluation (CPT 90792): ~$173 (therathink.com)
• 15-minute follow-up (CPT 99213): $92-96 (therathink.com)
• 25-minute follow-up (CPT 99214): $125-136 (therathink.com)
• 40-minute complex visit (CPT 99215): ~$192 (therathink.com)

If you add psychotherapy to a med management visit, add-on codes (90833 for 20-30 minutes of therapy) pay an additional ~$80.

For PMHNPs: Medicare pays 85% of these rates when billed under the NP’s NPI (www.nursepractitioneronline.com).

Private Insurance

Commercial insurance typically pays higher rates than Medicare, often 150-200% of Medicare rates in high cost-of-living areas. A major insurer might pay $150-200 for a 99213 and $200-250 for a 99214.

Many states have telehealth parity laws requiring insurers to pay the same for telehealth as in-person:

• Illinois: Strong parity through at least 2027 for behavioral health
• California: Payment parity required for contracts after 2021
• New York: Updated its law in 2021 to ensure telehealth reimbursement
• Texas: No mandated payment parity, but many insurers voluntarily pay equal rates for tele-mental health due to demand

Medicaid

Medicaid rates are generally lower than Medicare (typically 60-80% of Medicare rates), but Medicaid programs have expanded telehealth coverage permanently in most states. Many states also have telehealth parity for Medicaid — for instance, New York Medicaid reimburses tele-mental health at the same rate as face-to-face.

Audio-Only Visits

Medicare and some states now reimburse for audio-only (phone) mental health visits to improve access for patients without video capability. This was extended through 2024-2025 for mental health specifically. Useful for brief follow-up med checks with patients who lack video access.

The Bottom Line on Revenue

A psychiatrist doing 20 med management follow-ups per week (15-20 minutes each) at an average of $120 per visit generates $2,400/week or roughly $10,000/month in collections. Initial evaluations and longer visits increase this substantially.

On a platform handling patient acquisition, scheduling, and infrastructure, your time goes entirely to clinical care. No marketing overhead, no front desk staff managing appointment calls, no fighting with insurance companies over credentialing (if the platform handles that).

Frequently Asked Questions

Can psychiatrists prescribe Adderall and other stimulants via telehealth?

Yes. Under current federal DEA waivers (extended through December 31, 2025), psychiatrists can initiate Schedule II stimulants like Adderall or Vyvanse via video visit without an initial in-person exam (texasnp.org). You must conduct a thorough evaluation via secure video and check the state prescription monitoring program before prescribing. Most states explicitly allow this for psychiatric treatment.

Do PMHNPs need a collaborating physician in every state?

No. Approximately 34 states now grant full practice authority to NPs, meaning experienced PMHNPs can prescribe independently (www.nursepractitioneronline.com). States like Texas, Florida (for psych NPs), and Pennsylvania still require collaborative agreements. States like New York and Illinois require initial collaboration but grant independence after gaining experience (3,600 hours in NY, 4,000 hours in IL).

What’s the difference between MD and NP reimbursement?

Medicare reimburses NPs at 85% of physician rates when billed under the NP’s own NPI (www.nursepractitioneronline.com). Many private insurers follow similar policies. Some states have equal reimbursement laws, but this isn’t universal. From a revenue standpoint, this means an MD generates slightly higher per-visit revenue than an NP for the same service.

Can I prescribe controlled substances across state lines via telehealth?

Only if you hold an active medical license in the state where the patient is physically located during the visit. The Interstate Medical Licensure Compact (IMLC) helps expedite licensure in member states (Texas, Pennsylvania, and Illinois are members). You must comply with both federal DEA rules and the prescribing laws of the patient’s state.

What happens if the DEA changes the telehealth prescribing rules?

The DEA has proposed permanent rules that may require in-person exams or impose other restrictions after the current waivers expire. Providers should monitor DEA announcements expected in late 2024/early 2025. Likely scenarios include: requiring an in-person visit within a certain timeframe after initial teleprescription, limiting initial prescriptions to 30-day supplies, or creating a special telemedicine registration for controlled substance prescribing.

How do collaborative agreements work for telehealth PMHNPs?

In states requiring collaboration, the agreement must specify the NP’s scope of practice, prescribing authority, and supervision arrangements. Many states require the agreement to be filed with the nursing board. The collaborating physician must be available for consultation and typically must review a portion of the NP’s charts periodically (often 10% quarterly). For multistate telehealth practice, an NP may need separate collaborative agreements for each restricted state where they see patients.

What’s the typical patient acquisition cost for psychiatric services?

Through DIY marketing (SEO, Google Ads, directories), acquiring a qualified psychiatric patient typically costs $200-500+ when factoring in all costs — ad spend, optimization, staff time, no-shows from cold leads, and months of investment before results. Platforms that use a pay-per-appointment model eliminate upfront marketing spend and provide pre-qualified patients, offering more predictable economics and guaranteed ROI.

The Path Forward: Building a Sustainable Telehealth Practice

Whether you’re a psychiatrist with full prescribing authority or a PMHNP navigating state-specific scope rules, the fundamentals of building a sustainable telehealth practice come down to:

1. Staying compliant with federal and state prescribing rules
2. Understanding your scope and any collaborative requirements
3. Making smart economics decisions about patient acquisition

The traditional path — spend thousands on marketing, wait months for results, handle all the administrative overhead yourself — works for some providers. But it’s a gamble with your time and capital.

The alternative is joining a platform that handles patient acquisition, provides qualified leads, includes telehealth infrastructure, and lets you focus entirely on clinical care. You pay only when you see patients. No marketing risk. No months of investment with zero return. Just patients matched to your specialty, showing up for scheduled appointments.

For psychiatrists looking to expand their practice without the overhead of building and marketing a solo operation, and for PMHNPs who want to practice in states where they have authority without dealing with the complexity of multistate compliance and collaborative agreements, a platform model removes the friction.

Ready to see patients without the marketing headache? Explore how joining Klarity Health’s provider network gives you immediate access to qualified patients actively seeking psychiatric care — with no upfront marketing spend, no administrative overhead, and reimbursement structures that make sense. You focus on medicine. The platform handles everything else.

Sources and References

1. Texas Nurse Practitioners Association – ‘DEA Extends Telehealth Prescribing Flexibility Through 2025’ (texasnp.org) — Official professional association announcement citing DEA and HHS federal register extension, Oct 6, 2023.

2. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates from the Pandemic Era’ (natlawreview.com) — Legal analysis by healthcare attorneys summarizing federal DEA proposals and state telehealth rules including California and New York, Aug 15, 2025.

3. Florida Statutes Chapter 464.012 – ‘Controlled substance prescribing authority for advanced practice registered nurses’ (www.flsenate.gov) — Official Florida state statute defining psychiatric nurse prescribing authority and telehealth allowances for psychiatric treatment, 2024 compilation.

4. California Board of Registered Nursing – ‘AB 890 Implementation: 103 and 104 NP Certifications’ (www.rn.ca.gov) — Official state regulatory board website detailing California’s transition to nurse practitioner independence, updated Nov 2023 reflecting SB 1451.

5. JDSupra (Rivkin Radler LLP) – ‘New York Law Allows Experienced NPs to Practice Without Collaborative Relationship’ (www.jdsupra.com) — Law firm article summarizing New York Education Law changes in 2022 budget making NP independence permanent after 3,600 hours, April 13, 2022.

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship